跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 769 条关于
“N332-glycan”
全部
769
临床试验
580
药物
117
机构
2
资讯
70
7个月前
Single-Dose HIV Vaccine Candidate Induces Neutralizing Antibodies in Nonhuman Primates
去年
French Biotech Kyron.bio Raises €5.5M to Advance Glycan-Controlled Antibody Therapeutics
11个月前
GlycoNex Advances Novel Glycan-Targeted ADC GNX1021 for HER2-Low Gastric Cancer
去年
GlycoNex to Present Novel Glycan-Targeting ADC Data for Gastric Cancer at AACR 2025
8个月前
OBI Pharma and TegMine Therapeutics Form Global License Partnership for Novel Glycan-Targeting ADC
11个月前
UC Irvine Researchers Develop Pan-Cancer Immunotherapy Using Velcro-Like Glycan-Targeting Technology
3个月前
GlycoNex Doses First Patient in Phase I Trial of Glycan-Directed ADC GNX1021 for Advanced Solid Tumors
去年
Novel Glycan-Based Approach Shows Promise in Enhancing CAR-T Cell Therapy Efficacy
6个月前
kyron.bio Partners with Servier to Advance Precision Glycoengineering for Next-Generation Antibody Therapeutics
8个月前
IAVI Initiates Phase 1 Trial of Novel mRNA HIV Vaccine Targeting Broadly Neutralizing Antibodies
第 1 页,共 7 页
上一页
下一页